Structural Formula (41d7651e B91a 4118 8719 Bf2f663d82a2 01)
Donepezil Hydrochloride
Product Images NDC 67296-2058
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Donepezil Hydrochloride (NDC 67296-2058). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (41d7651e B91a 4118 8719 Bf2f663d82a2 02)
This text discusses the change in ADAS-cog scores from baseline after treatment with different doses of Donepezil hydrochloride (10 mg/day and 5 mg/day) and a placebo over the course of a certain number of weeks. The data possibly indicates clinical improvement with the treatment options. The format seems to include a table displaying the mean values and percentages of change in ADAS-cog scores for each treatment group.*
Figure 2 (41d7651e B91a 4118 8719 Bf2f663d82a2 03)
This text appears to be an evaluation of the cumulative percentage of patents in relation to the change in ADAS-cog scores for different treatments. It includes information about the placebo group, TeamentGuowp, and the Dosage of Donepezil hydrochloride. The data seems to be comparing the percentage change in ADAS-cog scores among the different treatment groups.*
Figure 3 (41d7651e B91a 4118 8719 Bf2f663d82a2 04)
Figure 4 (41d7651e B91a 4118 8719 Bf2f663d82a2 05)
ADAS-cog Change from Baseline showing mean improvement over different weeks of drug treatment with Donepezil hydrochloride 10 mg/day, Donepezil hydrochloride 5 mg/day, and Placebo. Clinical improvement is observed.*
Figure 5 (41d7651e B91a 4118 8719 Bf2f663d82a2 06)
This text seems to contain a table showing the treatment groups receiving different doses of Donepezil hydrochloride (10mg/day and 5mg/day) along with a placebo. It also mentions the percentage change in ADAS-cog for each group. The results are likely part of a study or clinical trial evaluating the effects of Donepezil hydrochloride on cognitive function in patients.*
Figure 6 (41d7651e B91a 4118 8719 Bf2f663d82a2 07)
Percentage of patients in a study receiving different treatments (donepezil 10mg/day, donepezil 5mg/day, placebo) showing improvement or worsening based on their CIBIC-plus rating. The results show the level of improvement or worsening experienced by the patients on each treatment.*
Figure 7 (41d7651e B91a 4118 8719 Bf2f663d82a2 08)
Figure 8 (41d7651e B91a 4118 8719 Bf2f663d82a2 09)
Figure 9 (41d7651e B91a 4118 8719 Bf2f663d82a2 10)
This text appears to be a table showing clinical improvement in patients using Donepezil hydrochloride 10mg/day compared to a placebo, as measured by the ADCS-ADL Change from Baseline after 3 months of drug treatment.*
Figure 10 (41d7651e B91a 4118 8719 Bf2f663d82a2 11)
5 (41d7651e B91a 4118 8719 Bf2f663d82a2 12)
This is the label information for Donepezil Hydrochloride tablets containing 5 mg of the active ingredient. The usual dosage information is provided in the accompanying package insert for prescribing guidance. It is recommended to store the tablets at a controlled room temperature. The manufacturer is Xungiao in Zhejiang, China, and they are distributed by PARMAGT in the USA. The label also includes a reference to further information available at solcohealthcare.com.*
10 (41d7651e B91a 4118 8719 Bf2f663d82a2 13)
This is information about Donepezil Hydrochloride tablets containing 10 mg each. The usual dosage instructions are provided in the package insert. The tablets should be stored at controlled room temperature. Dispensing should be done in a tight container. Patient information can be found at the provided website. The tablets are manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd. in China and distributed by Solco Healthcare US, LLC in the USA. Dispense patient information separately for each patient.*
3 (Image 01)
Each film-coated tablet contains Donepezil Hydrochloride 5 mg. The usual dosage information can be found in the accompanying package outsert for full prescribing information. Store the tablets at a controlled room temperature of 15°C to 30°C (59°F to 86°F). Dispense the tablets in a tight container (USP) and provide a patient information sheet to each patient. For more details, including patient information and drug labeling, visit www.solcohealthcare.com/druglabeling/donepezil-tablets.pdf. This medication is manufactured by Zhejiang Huahai Pharmaceutical Technology Co., Ltd in China and distributed by Solco Healthcare US, LLC in the USA. The package contains 30 tablets and the revision date is 08/2023.*
4 (Image 02)
Each film-coated tablet contains Donepezil Hydrochloride 10 mg. Usual Dosage: See accompanying package for full prescribing information. Store at controlled room temperature, 15°C to 30°C (59°F to 86°F). This product is manufactured by Zhejiang Huahai Pharmaceutical Technology Co., Ltd based in Linhai, Zhejiang, China, and distributed by Solco Healthcare US, LLC located in Somerset, NJ, USA. The item comes in a pack containing 30 tablets. For more details, visit the website provided or refer to the patient information sheet.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
